Clinical Trials Directory

Trials / Completed

CompletedNCT02209077

Spectralis OCT Repeatability and Reproducibility Study

Repeatability and Reproducibility of Optic Nerve Head (ONH), Retinal Nerve Fiber Layer (RNFL), and Macula Parameters With the Heidelberg Spectralis OCT.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Heidelberg Engineering GmbH · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

This single-center, prospective, interventional clinical study is conducted to evaluate the repeatability and reproducibility of structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT (Optical Coherence Tomography) device. Data obtained from healthy volunteers in this study are compared to those from a previous, larger healthy volunteer study that was conducted in the United States and Europe (S-2012-1), and data from glaucoma patients are compared to those from the healthy volunteers.

Detailed description

The study will include approximately 15 normal subjects and approximately 15 subjects who have glaucoma of varying degree. All subjects will undergo Spectralis OCT imaging and other study procedures in one single visit. All examinations performed on the subjects are non-significant risk procedures because the medical devices are cleared for marketing in Europe and in the U.S. Total study duration is anticipated to not exceed 4 weeks.

Conditions

Interventions

TypeNameDescription
DEVICEOCT performed to collect data from the back of the eyecomparative retinal parameters with Spectralis OCT

Timeline

Start date
2013-06-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2014-08-05
Last updated
2014-08-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02209077. Inclusion in this directory is not an endorsement.